A Randomized, Double-Masked, Controlled, Parallel-Group, Multicenter, Phase 2/3 Clinical Trial Investigating the Efficacy and Safety of ADX-2191 in Adults with Retinitis Pigmentosa
Clinical Trial Grant
Administered By
Ophthalmology, Vitreoretinal Diseases & Surgery
Awarded By
Aldeyra Therapeutics
Start Date
October 8, 2024
End Date
November 14, 2029
Administered By
Ophthalmology, Vitreoretinal Diseases & Surgery
Awarded By
Aldeyra Therapeutics
Start Date
October 8, 2024
End Date
November 14, 2029